Spiramycin: Difference between revisions

	WikiDoc Resources for Spiramycin
Articles
Most recent articles on Spiramycin Most cited articles on Spiramycin Review articles on Spiramycin Articles on Spiramycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Spiramycin Images of Spiramycin Photos of Spiramycin Podcasts & MP3s on Spiramycin Videos on Spiramycin
Evidence Based Medicine
Cochrane Collaboration on Spiramycin Bandolier on Spiramycin TRIP on Spiramycin
Clinical Trials
Ongoing Trials on Spiramycin at Clinical Trials.gov Trial results on Spiramycin Clinical Trials on Spiramycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Spiramycin NICE Guidance on Spiramycin NHS PRODIGY Guidance FDA on Spiramycin CDC on Spiramycin
Books
Books on Spiramycin
News
Spiramycin in the news Be alerted to news on Spiramycin News trends on Spiramycin
Commentary
Blogs on Spiramycin
Definitions
Definitions of Spiramycin
Patient Resources / Community
Patient resources on Spiramycin Discussion groups on Spiramycin Patient Handouts on Spiramycin Directions to Hospitals Treating Spiramycin Risk calculators and risk factors for Spiramycin
Healthcare Provider Resources
Symptoms of Spiramycin Causes & Risk Factors for Spiramycin Diagnostic studies for Spiramycin Treatment of Spiramycin
Continuing Medical Education (CME)
CME Programs on Spiramycin
International
Spiramycin en Espanol Spiramycin en Francais
Business
Spiramycin in the Marketplace Patents on Spiramycin
Experimental / Informatics
List of terms related to Spiramycin

Spiramycin
	File:Spyramycin.png
Clinical data
ATC code	J01FA02 (WHO) ;
Identifiers
PubChem CID	5356392;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C43H74N2O14
Molar mass	843.053 g/mol

VisualWikitext

Revision as of 19:49, 8 January 2014

Spiramycin is a macrolide antibiotic. It is used to treat toxoplasmosis. Although routinely used in Europe, spiramycin is still considered an experimental drug in the United States.^[1]

Used in Europe since 2000 year in name "Rovamycine", produced by Rhone-Poulenc Rorer, France and Eczacibasi Ilae, Turkey.

References

↑ Toxoplasmosis at MayoClinic.com

Template:WH Template:WS

[1] Toxoplasmosis at MayoClinic.com

[1]

v t e Antibacterials for systemic use: macrolides, lincosamides and streptogramins (J01F)
Macrolides	Erythromycin - Spiramycin - Midecamycin - Oleandomycin - Roxithromycin - Josamycin - Troleandomycin - Clarithromycin - Azithromycin - Miocamycin - Rokitamycin - Dirithromycin - Flurithromycin - Telithromycin - Cethromycin
Lincosamides	Clindamycin - Lincomycin
Streptogramins	Pristinamycin - Quinupristin/dalfopristin

Revision as of 16:13, 20 August 2012 (view source) WikiBot (talk \| contribs) m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) ← Older edit	Revision as of 19:49, 8 January 2014 (view source) Gerald Chi (talk \| contribs) m (Changed protection level for "Spiramycin" ([Edit=Allow only autoconfirmed users] (expires 19:49, 22 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 19:49, 22 January 2014 (UTC)))) Newer edit →
(No difference)

Clinical data
File:Spyramycin.png
ATC code	J01FA02 (WHO)
Identifiers
PubChem CID	5356392
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₄₃H₇₄N₂O₁₄
Molar mass	843.053 g/mol

Spiramycin: Difference between revisions

Revision as of 19:49, 8 January 2014

References

Navigation menu